| Gebruikt door |
als |
Naam |
Versie |
| 2.16.840.1.113883.2.4.3.11.60.20.77.10.9264 |
Inclusie |
 MP CDA Medication Contents (9)
|
2018‑12‑11 15:49:05 |
| 2.16.840.1.113883.2.4.3.11.60.20.77.10.9254 |
 |
MP CDA Medication Information (9)
|
2018‑12‑06 14:34:51 |
| 2.16.840.1.113883.2.4.3.11.60.20.77.10.9233 |
|
 MP CDA Medicatieafspraak inhoud (907)
|
2018‑12‑04 13:05:47 |
| 2.16.840.1.113883.2.4.3.11.60.20.77.10.9235 |
|
MP CDA Medicatieafspraak (907)
|
2018‑12‑04 14:33:21 |
| 2.16.840.1.113883.2.4.3.11.60.110.10.249 |
|
 VoorgeschiedenisMedicatie
|
2020‑09‑08 |
| 2.16.840.1.113883.2.4.3.11.60.20.77.10.9300 |
|
MP CDA Toedieningsafspraak inhoud (9)
|
2019‑11‑25 14:03:58 |
| 2.16.840.1.113883.2.4.3.11.60.20.77.10.9299 |
|
MP CDA Toedieningsafspraak (9)
|
2019‑11‑25 14:02:32 |
| 2.16.840.1.113883.2.4.3.11.60.20.77.10.9263 |
|
MP CDA Medication Information Proposal Statement (9)
|
2018‑12‑11 15:40:12 |
| 2.16.840.1.113883.2.4.3.11.60.20.77.10.9279 |
|
MP CDA Medicatiegebruik inhoud (9)
|
2019‑11‑21 14:15:51 |
| 2.16.840.1.113883.2.4.3.11.60.20.77.10.9281 |
|
MP CDA Medicatiegebruik (9)
|
2019‑11‑21 14:26:45 |
| Gebruikt |
als |
Naam |
Versie |
| 2.16.840.1.113883.2.4.3.11.60.20.77.10.9071 |
Containment |
MP Ingredient quantity (9)
|
2016‑06‑18 20:41:53 |
| 2.16.840.1.113883.2.4.3.11.60.20.77.10.9073 |
Inclusie |
MP CDA Ingredient Material Kind (9)
|
2016‑06‑18 20:55:06 |
ent)